You are here:Home/Scientific Sessions/4/23/21 – NYACC Endorses Management of Cardiometabolic Risk in Inflammatory...
More information coming soon!
NYACC endorses NYU CME Course “Management of Cardiometabolic Risk in Inflammatory Conditions: Improving treatment in psoriasis, inflammatory arthritis, systemic lupus erythematosus and HIV”
This one-day course will cover state-of-the-art clinical management of patients at elevated risk of cardiometabolic disease due to pro-inflammatory conditions. This course is designed to provide an informative and practical guide towards the clinical management of cardiometabolic risk in patients with diagnosis such as psoriasis, systemic lupus erythematosus (SLE), inflammatory arthritis, and HIV. The course will highlight the association and recent data linking systemic inflammation and cardiovascular disease including covering such landmark trials as the CANTOS trial and how certain conditions including HIV and psoriasis drive vascular inflammation. A series of speakers will discuss clinical pearls in the identification and management of cardiometabolic risk in psoriasis, SLE, inflammatory arthritis, and HIV. Attendees will also be provided with novel insights into the link between inflammation and cardiovascular disease with a specific focus on platelets, the microbiomes, and vascular endothelial disturbances. The course will also briefly review the interaction between diet, lifestyle, and systemic inflammation. Finally, experts will discuss their own experiences, practical approaches and lessons learned from a cardio-rheumatology clinic.
The course is jointly sponsored by the NYU Grossman School of Medicine and the National Heart, Lung and Blood Institute and occurring virtually on Friday, April 23, 2021.
Management of Cardiometabolic Risk in Inflammatory Conditions: Improving treatment in psoriasis, inflammatory arthritis, systemic lupus erythematosus and HIV